| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,685 | 36,940 | 35,220 | 33,026 | | Cost of Revenue | 8,831 | 7,947 | 8,489 | 10,069 | | | Gross Profit | 29,854 | 28,993 | 26,731 | 22,957 | | | Operating Expenses | | Research Development | 6,343 | 6,073 | 5,551 | 5,110 | | Selling General and Administrative | 25,589 | 25,278 | 26,800 | 24,744 | | Non Recurring |
-
|
-
|
-
| (971) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,078) | (2,358) | (5,620) | (5,926) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 481 | 132 | 155 | | Earnings Before Interest And Taxes | (1,868) | (1,877) | (5,488) | (5,771) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,868) | (1,877) | (5,488) | (5,771) | | Income Tax Expense | 104 | 444 | 194 | 208 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,972) | (2,321) | (5,682) | (5,979) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,972) | (2,321) | (5,682) | (5,979) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,972) | ($2,321) | ($5,682) | ($5,979) |
|
0.20% Nasdaq 
0.59 (3.56%) 
Income Statement
